The USP10/13 inhibitor, spautin-1, attenuates the progression of glioblastoma by independently regulating RAF-ERK mediated glycolysis and SKP2.
Article in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (June 2024)
The most recent citing publications are shown below. View all 493 publications that cite this research output on Dimensions.
Article in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (June 2024)
Article in Reviews in the Neurosciences (June 2024)
Article in Neuro-Oncology (June 2024)